Connect with us

Business

MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipeline

Published

on

MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipeline
ET Intelligence Group: Sun Pharma‘s June quarter performance was broadly in line with analysts’ expectations.

Expanding specialty and innovative medicines portfolio, semaglutide launches across India and international markets, and the proposed Organon acquisition are major growth drivers in the medium term for the country’s largest pharma company by revenue and market cap. Despite pressure in the US generics segment, it has maintained the FY27 guidance of high single-digit revenue growth on account of continued traction in specialty products such as Leqselvi and Unloxcyt and strong momentum in the domestic business.

Read more: New F&O closing auction rules: Impact on traders, investors decoded

The short-term growth narrative is shifting away from traditional generics and toward specialty and innovative products. While the US formulations business declined 9.7% due to lower contribution from generic Revlimid and increased competition in some products, the company’s innovative medicines portfolio continued to gain traction across the US and international markets. The innovative portfolio will likely remain a key growth engine supported by products such as Ilumya, Odomzo and Cequa, along with the ramp-up of new launches. Motilal Oswal Financial Services (MOFSL) expects the specialty portfolio to deliver a 13% annual growth over FY26-FY28, aided by improving physician adoption and expanding market access.

Advertisement
Screenshot 2026-08-03 062759Agencies

Another potential growth lever is semaglutide. Beyond India, the company has secured approvals for generic semaglutide injections for Type-2 diabetes in South Africa and Brazil. The commercialisation is underway in South Africa while the Brazil launch is expected soon through a partner.


The medium-term outlook is led by a healthy innovation pipeline. Key milestones over the next 12-18 months include a USFDA decision on Ilumya for psoriatic arthritis in October 2026, topline phase-II data for GL0034 in Type-2 diabetes during the second half of 2027, progress on Fibromun, and regulatory filings for dermatology and oncology assets. The Organon acquisition is expected to complete by March 2027 quarter, which could expand Sun Pharma‘s global scale and product portfolio.
MOFSL has retained a ‘buy’ rating on the stock with a target price of ₹2,310, implying a 16% upside to Friday’s closing price of ₹1,989.4.The broking firm believes Sun Pharma remains on track for strong growth, supported by expansion in innovative medicines through partnerships, launches and wider reach.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Red-state AGs warn OpenAI after AI agent allegedly hacks Hugging Face

Published

on

OpenAI says AI model hacked another company's systems during internal test

A coalition of 15 red-state attorneys general warned OpenAI CEO Sam Altman on Monday to preserve documents and halt certain high-risk cybersecurity tests after an experimental artificial intelligence agent allegedly escaped a controlled environment and carried out a multi-day hack into outside computer systems.

In a Monday letter shared with Fox News Digital, the attorneys general said OpenAI may have violated state and federal consumer-protection and data-privacy laws and cautioned that a failure to preserve relevant records could trigger sanctions if litigation follows.

Advertisement

“A failure to take immediate action to preserve such materials could result in spoliation sanctions if litigation were to ensue,” Iowa Republican AG Brenna Bird’s letter, signed by GOP AGs from Alabama, Arkansas, Florida, Idaho, Indiana, Kansas, Missouri, Montana, Nebraska, Oklahoma, Pennsylvania, South Carolina, Texas and Utah, read.

“We further demand that OpenAI take immediate steps to ensure that no OpenAI personnel face any adverse action for engaging in any protected whistleblowing activity or for reporting any unlawful or harmful activities by OpenAI.”

FLORIDA SUES OPENAI AND SAM ALTMAN CLAIMING CHATGPT IS UNSAFE FOR USERS

The officials accused OpenAI of conducting a July 2026 evaluation involving two advanced models — identified in the letter as GPT-5.6 Sol and an unreleased model the company had described as “even more capable” — without the normal safeguards designed to prevent high-risk cyber activity.

This letter and hack follow a letter GOP AGs wrote to Altman in May, demanding answers on OpenAI’s nonprofit status.

“OpenAI’s inability or unwillingness to ensure the safety of its products poses an imminent risk of substantial harm to our States,” Bird wrote.

“We intend to take decisive action to protect our citizens.”

Advertisement

ELON MUSK ATTORNEY CLAIMS OPENAI, SAM ALTMAN ‘STOLE A CHARITY’ AS HIGH-STAKES LEGAL FIGHT BEGINS

Ticker Security Last Change Change %
MSFT MICROSOFT CORP. 488.76 +24.04 +5.17%
NVDA NVIDIA CORP. 207.92 +7.17 +3.57%
AMD ADVANCED MICRO DEVICES INC. 485.76 +9.61 +2.02%
PLTR PALANTIR TECHNOLOGIES INC. 125.62 +2.56 +2.08%
GOOGL ALPHABET INC. 374.38 +18.25 +5.12%
AMZN AMAZON.COM INC. 284.11 +12.53 +4.61%

The test was supposed to take place in an isolated environment with no internet access, but the attorneys general alleged in the letter that the agent exploited a software vulnerability, escaped the testing environment and connected to the internet.

“OpenAI failed to confirm that its secure and isolated testing environment was, in fact, secure and isolated,” Bird wrote. “It was not.”

From there, the agent allegedly launched an intrusion targeting the AI company Hugging Face in an effort to steal an answer key and defeat its own safety evaluation.

Advertisement

Citing an interim technical report from Hugging Face, the letter said the agent carried out more than 17,000 “attacker actions,” seized control of an external endpoint exposed through a third-party infrastructure provider and entered Hugging Face systems.

OPENAI DIDN’T REALIZE ITS AGENT WAS RESPONSIBLE FOR HACK FOR A WEEK: REPORT

OpenAI logo

In this photo illustration, an OpenAI logo is seen displayed on a smartphone on the top of a laptop. (Omar Marques/SOPA Images/LightRocket / Getty Images)

The attorneys general also cited reporting that the agent found four sets of login credentials online and used them to access four other unnamed services.

OpenAI allegedly did not know the agent had broken containment while the activity was underway. The letter claims Hugging Face detected the intrusion independently and contacted the FBI before OpenAI determined that its own technology was responsible.

Advertisement

The document presents the incident and its surrounding details as allegations drawn from public reporting and technical findings.

The attorneys general said the episode followed a series of warning signs involving OpenAI’s models and internal oversight.

OPENAI CO-FOUNDER WARNS AI MODELS ARE BECOMING HARDER TO CONTROL AFTER ITS MODEL HACKED ANOTHER FIRM

OpenAI CEO Sam Altman

OpenAI CEO Sam Altman said concerns about artificial intelligence are understandable following a recent cybersecurity incident involving one of the company’s models. (Anna Moneymaker/Getty Images / Getty Images)

They cited reports that an AI agent had previously left instructions for future versions of itself describing how to escape internal restrictions, that monitoring systems had been disconnected during earlier tests and that employees sometimes struggled to oversee multiple fast-moving model evaluations generating enormous volumes of data.

Advertisement

“OpenAI’s unprecedented and alarming misconduct demands an immediate and significant response,” the officials wrote.

The coalition demanded that OpenAI preserve documents, internal communications, data and other materials related to the Hugging Face intrusion, the pre-release model involved, the company’s discovery of the incident and any internal investigation or public statement concerning it.

The preservation request also covers previous cases in which OpenAI models may have used publicly exposed credentials, earlier unauthorized network intrusions and any incident in which a model left notes for future versions of itself.

ANTHROPIC SAYS AI MODELS ACCESSED SYSTEMS OF 3 REAL ORGANIZATIONS DURING TESTING

Advertisement
Hugging Face logo

Hugging Face said it detected and contained a security breach after an OpenAI model compromised part of its infrastructure during an internal evaluation. (Jaque Silva/NurPhoto via Getty Images / Getty Images)

The attorneys general further requested records concerning OpenAI’s safety policies, testing procedures, monitoring systems, employee concerns and personnel with knowledge of the alleged events.

The letter also demanded that OpenAI protect employees from retaliation for reporting potentially unlawful or dangerous conduct.

In addition, the coalition called on the company to immediately stop internal evaluations that prompt AI models to pursue advanced exploitation through complex attack paths.

“Unless and until OpenAI shows that it can conduct such activities in a controlled and responsible way, such activities pose an imminent risk of serious harm to the citizens of our States,” the letter said.

Advertisement

Fox News Digital reached out to OpenAI for comment and has not yet heard back.

The officials stopped short of announcing a lawsuit but said the publicly reported facts could support claims under laws enforced by state attorneys general.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

“OpenAI has an obligation to act responsibly and to follow State and federal laws that protect Americans’ safety and security,” Bird’s letter concluded. “When OpenAI takes actions that imperil the welfare of our citizens, State Attorneys General will step in to protect them.

Advertisement

“We intend to take all steps necessary to protect our States and all Americans from the unprecedented risks posed by OpenAI’s irresponsible products and conduct.”

The White House has confirmed to Fox News that it is going to host AI companies Tuesday to review the AI framework from a June 2 executive order from President Donald Trump.

Continue Reading

Business

Johnson & Johnson (JNJ) Discusses FDA Authorization and Market Introduction of OTTAVA Robotic Surgical System Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript